5 Revealing Analyst Questions From Markel Group's Q2 Earnings Call

Markel Group’s Q2 results reflected a quarter of transition, as management executed a significant restructuring of its insurance operations and initiated runoff of underperforming segments. CEO Tom Gayner cited a renewed focus on core specialty insurance lines and decentralization of profit and loss accountability as key themes. The quarter was also marked by increased reserves for discontinued D&O and reinsurance books, which management attributed to adverse loss developments. CFO Brian Costanzo added that, while some product lines experienced setbacks, the underlying insurance business and international operations continued to perform well.

Is now the time to buy MKL? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Markel Group’s Q2 Earnings Call

• Andrew Kligerman (TD Cowen) asked about capital freed up by the reinsurance runoff and how it might be redeployed. CFO Brian Costanzo explained that capital release will be gradual as reserves run down, and investment income will continue from assets backing runoff liabilities.
• Andrew Kligerman (TD Cowen) sought clarity on the Programs and Solutions segment, specifically delegated underwriting by MGAs. Costanzo said roughly one-third of premiums come from such programs, which are managed for long-term profitability.
• Maxwell Fritscher (Truist) inquired about the workers’ compensation line’s contribution and any signs of medical inflation. Costanzo noted steady favorable development and careful monitoring of medical inflation, with the business remaining profitable so far.
• Maxwell Fritscher (Truist) asked if the current accident year loss ratio is a good indicator for the rest of the year. Costanzo responded affirmatively, highlighting the effect of past underwriting actions.
• Andrew Andersen (Jefferies) questioned the rationale for exiting the risk-managed D&O book. CEO Simon Wilson explained that higher-than-expected claim severity turned excess layers into working layers, prompting decisive reserve actions and runoff.

Catalysts in Upcoming Quarters

Going forward, the StockStory team will monitor (1) the pace of improvement in Markel Insurance’s combined ratio as runoff and restructuring actions take hold, (2) the effectiveness of decentralized expense management in reducing overall costs, and (3) capital deployment strategies as assets are gradually released from runoff books. Continued progress in international operations and specialty lines will also be key to tracking the company’s long-term transition.

Markel Group currently trades at $1,928, down from $2,005 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).

The Best Stocks for High-Quality Investors

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.